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Edited by Sandro SonninoAbstract The physiological functions of cellular prion protein
(PrPC) remain unclear. It has been demonstrated that PrPC is
a copper binding protein and proposed that its functions could
be strictly linked to copper metabolism and neuroprotection.
The aim of this study was to clarify how extracellular copper
modiﬁes PrPC expression and metabolism in cultured neurones.
We reported here that copper delivered at physiological concen-
trations signiﬁcantly decreases PrPC mRNA expression in
GN11 neurones. Moreover, copper increases the release of PrPC
into the culture medium. These results indicate that extracellular
copper strongly aﬀects the amount of cellular PrP and might rep-
resent an interesting strategy to decrease the expression of PrPC
in neurones and its conversion in the pathological isoform PrPSc.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Hundreds of studies have focused on prion protein and prion
diseases. Nevertheless, the physiological role of native cellular
prion protein still remains unknown, even if fundamental func-
tions of this protein are suggested by its high conservation
throughout evolution [1]. Cellular prion protein (PrPC) is a N-
glycosylated glycosyl-phosphatidylinositol-anchored protein,
ubiquitously expressed on the cell membrane, predominantly
in the brain, but also in a wide variety of peripheral tissues [2].
Since PrPC is mainly localised on the cell membrane, its physio-
logical role could reasonably be related to ligand uptake, cell
signalling or cell adhesion [3]. Many independent studies dem-
onstrate the property of this protein to reversibly bind copper
ions with high capacity and suitable stability constant values,
suﬃcient to indicate that this protein plays an important role
in copper homeostasis [4,5]. Strict relationships between copper
ions and PrPC physiology are also suggested by the fact that var-
ious insertional mutations within the copper binding region of
PrPC have been associated with human prion diseases [6].More-
over, serious neurodegeneration has been observed in PrP*Corresponding author. Fax: +39 51 209 42 86.
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the copper binding domain [7]. Other indirect evidence of this
functional link comes from the demonstration that cellular cop-
per concentration was decreased inPrnp-deﬁcient neuronal cells
[8]. It is well established that PrPC is constitutively endocytosed
via caveolae [9] or via clatrin coated pits [10]. Copper ions rap-
idly and reversibly stimulate both these endocytic pathways [11].
There is increasing evidence that PrPC has physiological func-
tions in the cellular resistance to oxidative stresses [12–14] and
it has been proposed that this may be due to altered activity
of the copper-dependent superoxide dismutase (SOD-1) enzyme
[15]. These convincing data point to an involvement of PrPC in
copper metabolism and, probably, to a role of this glycoprotein
in copper delivery to cytosolic cuproenzymes. PrPC expression is
highly regulated during development [16] and in cultured neuro-
nes [17,18]. A set of investigations focus on the regulation of
Prnp expression [19,20]. Such regulation is essential in the com-
prehension of PrPC physiology, as well as in prion diseases, in
which the reduction of the amount of PrPC could be a therapeu-
tic approach for delaying the development of these fatal disor-
ders. Recently, Parkin and collaborators [21] have shown that
PrPC can be shed into themedium of cultured neurones and that
extracellular copper could be one of the physiological stimuli
that regulate this shedding. Our results support the view that
extracellular copper, at physiological concentration, regulates
the amount of PrPC bound to neuronal cell membrane since they
indicate that extracellular copper is a key regulator of PrPC
metabolism, at least in some neuronal populations.2. Materials and methods
2.1. Reagents and antibodies
Foetal bovine serum was purchased from BioWhittaker (Cambrex,
East Rutherford, USA). Trizol reagent was from Euroclone (Lugano,
Switzerland), Megaprime DNA labelling system and ECL detection
system were from Amersham (UK). All the other reagents were pur-
chased from Sigma (Sigma Chemical, St. Louis, USA). Anti-PrP poly-
clonal antibody was anti-bovine prion protein (R10) from Roboscreen
(Germany), that recognises murine natural PrPC, while polyclonal
antibodies to 5 0-nucleotidase (CD73) and to b-actin were from Santa
Crutz Biotechnology (USA).2.2. Cell culture
Murine GN11 cells were grown in high glucose DMEM, supple-
mented with 10% foetal calf serum, 2 mM L-glutamine, penicillin
(100 U/ml) and streptomycin (100 lg/ml), as described in [22]. Forblished by Elsevier B.V. All rights reserved.
Fig. 1. Northern-blot analysis of PrPC and b-actin mRNA expression
in GN11 neurones cultured with increasing extracellular copper
concentrations. (A) Cells were cultured for 96 h with culture medium
(lane 1) or with the addition of CuSO4 5–40 lM (lanes 2–5). Lane 6
refers to cells cultured with medium containing CuSO4 (40 lM) and
cuprizon (40 lM). In lane 7, culture medium was supplemented with
40 lM MgSO4, while in lane 8 with 40 lM ZnSO4. Band quantiﬁca-
tion, plotted in (B), represents the average ± S.E.M. of three diﬀerent
experiments, performed under identical conditions. * indicates statis-
tically signiﬁcant diﬀerences (P < 0.05).
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96 h in the absence or in the presence of CuSO4 (5–40 lM), MgSO4
(40 lM) or ZnSO4 (40 lM).
2.3. Northern blot
Total RNA from subconﬂuent GN11 cells was puriﬁed by using Tri-
zol Reagent, according to the manufacturers instructions. Total RNA
(10 lg) was separated in a 1.2% agarose–formaldehyde gel and trans-
ferred to Hybond-N+ membrane. Mouse PrPC cDNA fragment
(222–917) and mouse b-actin fragment (689–1198) were obtained and
labelled as previously described [23]. Membranes were exposed to X-
ray ﬁlm at 80 C and after ﬁlm developing bands were quantiﬁed
by using image analysis software (Image Master, Pharmacia Biotech.,
Sweden). Diﬀerences were analysed by Students t test and considered
statistically signiﬁcant at P < 0.05.
2.4. Western blot
Surnatant proteins were collected after 8 h of incubation in Opti-
mem without serum and precipitated by using TCA. Deglycosylated
cell lysates or surnatante proteins were obtained by incubation with
5 U of PNGase F for 24 h at 37 C. Proteins were separated by a
12% SDS–PAGE and then electrophoretically transferred onto nitro-
cellulose. Nitrocellulose was cut in two parts and incubated with
polyclonal anti-PrP antibody (dilution 1:1000), or with polyclonal
anti-5 0-nucleotidase antibody (dilution 1:200). Immunolabelling was
visualised by using the ECL procedure. Bands were quantiﬁed as de-
scribed above. Normalisation was made against b-actin expression.
All results are expressed as means ± S.E.M.
2.5. Triton X-114 phase partitioning
To examine the hydrophobic properties of PrPC, cells lysed in TNE
buﬀer or surnatant proteins were partitioned in aqueous and detergent
phases by using Triton X-114, as described in [24]. Proteins of each
phase were precipitated with ﬁve volumes of methanol before Wes-
tern-blot analysis. For cleavage of GPI anchor, samples were incu-
bated for 2 h at 37 C with 1 U/ml of Bacillus cereus PI-PLC.3. Results
3.1. Copper regulates PrPC mRNA expression in GN11 cells
To assess whether extracellular copper could modulate PrPC
mRNA expression, we cultivated neuronal GN11 cells for
96 h in the presence of copper (5–40 lM). In complete culture
medium only traces of copper ions (0.0053 ppm) were present,
according to atomic absorption data. Northern-blot analysis
(Fig. 1) showed that increasing copper concentrations resulted
in a signiﬁcant decrease of the expression level of PrPC mRNA.
We observed that 10 lM copper decreased 2-fold this expres-
sion and 40 lM copper further decreased the steady-state
expression of PrPC mRNA (Fig. 1, lanes 1–5). These copper
concentrations are in the range of physiological values mea-
sured in mammalian brains [25]. To demonstrate the speciﬁcity
of this eﬀect, we added cuprizon, a speciﬁc copper chelator
(40 lM), to the medium containing 40 lM copper (Fig. 1, lane
6). Cuprizon up to 100 lM did not aﬀect GN11 viability or
GN11 proliferation rate. Results demonstrated that cuprizon
treatment completely restored the decreased expression of PrPC
mRNA induced by copper. The speciﬁcity of copper eﬀects was
also tested by adding other divalent cations to the culture med-
ium (Fig. 1, lanes 7 and 8). Neither Mg2+ (40 lM) nor Zn2+
(40 lM) showed any eﬀect on PrPC mRNA expression.
3.2. Copper regulates PrPC shedding
Since Parkin and collaborators have shown that copper
could regulate PrPC shedding, we analysed the quantity of
the protein contained in conditioned media of mouse GN11neurones after 0–96 h of incubation with 40 lM copper. By
Western-blot analysis, we observed that the presence of copper
strongly increased the amount of deglycosylated PrPC con-
tained into the medium (Fig. 2A). The speciﬁcity of this shed-
ding was tested by adding other divalent cations to the culture
medium (Fig. 2A): Neither Mg2+ (40 lM) nor Zn2+ (40 lM)
showed any eﬀects on the amount of PrPC released into the
medium. Moreover, cuprizon almost completely inhibits PrPC
shedding (not shown). To verify if this shedding was speciﬁc to
PrPC or if it involved other GPI-anchored proteins, we evalu-
ated the shedding of 5 0-nucleotidase. Results indicate (Fig. 2C)
that neither Cu2+(40 lM) nor Mg2+ (40 lM) nor Zn2+ (40 lM)
had any eﬀect on 5 0-nucleosidase shedding. When conditioned
media of copper-treated GN11 were subjected to phase parti-
tioning in Triton X-114 (Fig. 3), more than 80% of PrP was de-
tected in the aqueous phase, conﬁrming the lack of GPI anchor
in the PrP released into the medium.
3.3. Copper strongly decreased the amount of cellular PrPC
Since copper treatment decreased PrPC mRNA expression
and simultaneously increased PrPC shedding, we expected a
synergy of these two copper-induced eﬀects on PrPC expression
in GN11 neurones. To this end, we measured the amount of
deglycosylated PrPC in cellular lysates by Western blot. Re-
sults reported in Fig. 4 indicate that a signiﬁcant 5-fold reduc-
tion in PrPC expression was evident after 72–96 h of 40 lM
copper treatment. Neither Mg2+ nor Zn2+ signiﬁcantly modi-
ﬁed PrPC amount measured in GN11 cellular lysates.4. Discussion
It is well known that in eukaryotic cells, copper can modu-
late the expression of copper transport proteins [26]. Studies
Fig. 2. Western-blot analysis of PrPC and 5 0-nucleotidase shedding in
GN11 neurones cultured in the presence of copper. (A) Cells were
cultured for 24–96 h with culture medium containing CuSO4 (40 lM),
MgSO4 (40 lM) or ZnSO4 (40 lM). Western blot of deglycosylated
surnatant proteins was performed for PrPC detection. (B) Band
quantiﬁcation of (A) shows the average ± S.E.M. of three diﬀerent
experiments, performed under identical conditions. (C) Western blot of
the timing of 5 0-nucleotidase shedding. (D) Band quantiﬁcation of (C)
representing the average ± S.E.M. of three diﬀerent experiments. *
indicates statistically signiﬁcant diﬀerences (P < 0.05).
Fig. 4. Western-blot analysis of PrPC expression in GN11 neurones
cultured in the presence of copper. (A) Cells were cultured for 0–96 h
with culture medium containing CuSO4 (40 lM) or MgSO4 (40 lM) or
ZnSO4 (40 lM). Western blot of deglycosylated cell lysates proteins
was performed for PrPC detection. (B) Band quantiﬁcation of (A)
shows the average ± S.E.M. of three diﬀerent experiments, performed
under identical conditions. * indicates statistically signiﬁcant diﬀer-
ences (P < 0.05).
Fig. 3. Phase separation of shed PrP. (A) GN11 membranes (lanes 1–
4) and conditioned media (lanes 5–8) were subjected to Triton X-114
phase separation, and the resultant detergent-rich (Dr) and aqueous
(Aq) phases were analysed by Western blot. Lanes 3 and 4 show the
result of PI-PLC digestion of membrane-bound PrPC, while lanes 7
and 8 show the eﬀect of 96 h of 40 lM copper treatment. (B) Band
quantiﬁcation of (A) expressed in terms of the percentage distribution
of PrP between the two phases (average ± S.E.M., n = 3).
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expression showed contrasting results. While some papers con-
cluded that copper had no eﬀects on the expression of PrPC
[27], other studies observed that copper ions strongly inﬂu-
enced PrPC accumulation. Hijazi et al. [25] found that extracel-
lular copper increased PrPC accumulation in N2a neurones,
while Nishimura et al. [28] have recently observed a decreased
expression of PrPC in cerebellar granular neurones cultured in
the presence of copper. PrPC accumulation was also recorded
in the cerebellum, but not in the total brain, of copper-treated
healthy hamsters [25]. A possible explanation for these diﬀer-
ent results is that diﬀerent neurones respond to extracellular
copper in diﬀerent manners as far as the expression of PrPC
is concerned. In the present study, we have investigated the ef-
fects of extracellular copper on PrPC expression in hypotha-
lamic GN11 neurones. We found that copper ions strongly
aﬀect the total amount of PrPC by decreasing its mRNA level
and by increasing the release into the medium of a PrP devoid
of GPI anchor. Parkin and collaborators [21] have analysedthe mechanism of copper-induced PrPC shedding in neurones,
concluding that it depends on the proteolytic activity of a cop-
per-dependent zinc metalloprotease. We show here that this ef-
fect is independent from other divalent cations, such as Mg2+
and Zn2+, suggesting that this is a speciﬁc copper-dependent
mechanism. Our data demonstrate that, at least in some
744 M. Toni et al. / FEBS Letters 579 (2005) 741–744neuronal populations, extracellular copper concentrations
strongly and rapidly aﬀect the amount of native cellular PrPC.
In these neurones, extracellular copper strongly reduces the
amount of PrPC available for subsequent conversion to its
pathological isoform (PrPSc). Moreover, copper-induced PrPC
internalisation in neurones is a well known phenomenon [11]
that further decreases the amount of membrane-bound PrPC.
Our results clearly show that extracellular copper ions may
eﬃciently modulate PrPC mRNA levels. They also support
the view that PrPC physiological functions could be strictly
linked to copper ions. Nevertheless, much literature is devoted
to analyse the involvement of PrPC on cellular signalling [3]
and we, as well, have collected results demonstrating that PrPC
antibody ligation strongly aﬀects ERK 1/2 signalling in GN11
neurones (Toni et al., unpublished results). It is very likely that
PrPC physiological functions, in addition to PrPC synthesis,
PrPC shedding and PrPC internalisation, depend on the ratio
copper-free/copper-loaded PrPC.
The understanding of copper homeostasis has become really
essential in neuronal cell physiology, since this metal has been
involved in the pathogenesis of some important neurological
disorders such as Creutzfeldt-Jakob disease, Alzheimers dis-
ease, Parkinsons disease and amyotrophic lateral sclerosis
[29]. We believe that the comprehension of the pathogenesis
of prion disease and other main neurodegenerative pathologies
should focus on the cellular and molecular mechanisms at the
basis of copper homeostasis and transport.
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